Enodia Therapeutics

Developer of small-molecule therapies for inflammatory and autoimmune diseases

placeParis, Ile De France, France calendar_todayFounded 2025 language enodiatx.com

Social engagement

Social engagement: 1.7K social following, 7 posts in the last 12 months — top 10% of its industry.

Investor mix

10 investors on record; lead investors include Elaia, Pfizer, Bpifrance.

Investor typeCountShare
Venture capital330%
Private equity110%
Bank & private debt110%
Other / undisclosed550%

Recent activity

9 Jun 2026
Recognition
15 Apr 2026
Leadership hire
Chief Scientific Officer
26 Mar 2026
Expansion
Villajuif, Villejuif
Coming soon